SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease

@inproceedings{Shehadeh2010SRRM2AP,
  title={SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease},
  author={Lina A. Shehadeh and Kristine Yu and Liyong Wang and Alexandra Guevara and Carlos Singer and Jeffery Vance and Spyridon Papapetropoulos},
  booktitle={PloS one},
  year={2010}
}
BACKGROUND Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects about five million people worldwide. Diagnosis remains clinical, based on phenotypic patterns. The discovery of laboratory markers that will enhance diagnostic accuracy, allow pre-clinical detection and tracking of disease progression is critically needed. These biomarkers may include transcripts with different isoforms. METHODOLOGY/PRINCIPAL FINDINGS We performed extensive analysis on 3 PD microarray… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 35 extracted citations

Parkinson's disease: molecular risk factors.

Parkinsonism & related disorders • 2012
View 13 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 39 references

Molecular markers of early Parkinson's disease based on gene expression in blood.

Proceedings of the National Academy of Sciences of the United States of America • 2007
View 17 Excerpts
Highly Influenced

Gene Expression Profiling in Parkinson’s disease: Discovery of valid biomarkers, molecular targets and biochemical pathways

S Papapetropoulos, D McCorquodale
Future Neurol • 2007
View 1 Excerpt

Similar Papers

Loading similar papers…